From: Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer
Factor
HR
95% CI
p-value
HRD (positive vs. negative)
0.463
0.265–0.810
0.0069
Stage (IV vs. III)
1.322
0.588–2.972
0.4991
Residual Tumor:
 R0
-
 R1
1.002
0.572–1.754
0.994
 R2
1.082
0.413–2.833
0.873